Neogen (NEOG) Current Deferred Tax Assets (2011 - 2017)
Neogen's (NEOG) quarterly Current Deferred Tax Assets came in at $1.7 million in Q1 2017, down 23.81% year-on-year from $2.3 million in Q1 2016, and little changed quarter-over-quarter from $1.7 million in Q4 2016.
Neogen (NEOG) Current Deferred Tax Assets (2011 - 2017) Analysis & Trends
Neogen's Current Deferred Tax Assets history runs 7 years deep, the most recent figure standing at $1.7 million for Q1 2017.
- On a quarterly basis, Current Deferred Tax Assets fell 23.81% year-over-year to $1.7 million in Q1 2017; TTM through Feb 2017 was $1.7 million, a 23.81% decrease from a year earlier, with the FY2016 full-year figure at $1.8 million, down 10.85% from the prior year.
- Current Deferred Tax Assets held at $1.7 million in Q1 2017 per NEOG's latest filing, from $1.7 million in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $2.3 million in Q3 2015 and bottomed at $1.3 million in Q1 2013.
- The 5-year median for Current Deferred Tax Assets is $1.7 million (2014), against an average of $1.8 million.
- Across the five-year window, Current Deferred Tax Assets soared 36.9% in 2015 and dropped 23.81% in 2017, its largest moves.
- Year by year, Current Deferred Tax Assets stood at $1.5 million in 2013, then climbed by 16.96% to $1.7 million in 2014, then surged by 34.09% to $2.3 million in 2015, then fell by 23.77% to $1.7 million in 2016, then fell by 0.06% to $1.7 million in 2017.
- Per Business Quant, the three latest NEOG Current Deferred Tax Assets figures stand at $1.7 million (Q1 2017), $1.7 million (Q4 2016), and $1.8 million (Q3 2016).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2017 | 1.75 Mn |
| Feb 28, 2017 | 1.75 Mn |
| Nov 30, 2016 | 1.75 Mn |
| Nov 30, 2016 | 1.75 Mn |
| Aug 31, 2016 | 1.76 Mn |
| Aug 31, 2016 | 1.76 Mn |
| May 31, 2016 | 1.78 Mn |
| May 31, 2016 | 1.78 Mn |
| Feb 29, 2016 | 2.29 Mn |
| Feb 29, 2016 | 2.29 Mn |
| Nov 30, 2015 | 2.29 Mn |
| Nov 30, 2015 | 2.29 Mn |
| Aug 31, 2015 | 2.30 Mn |
| Aug 31, 2015 | 2.30 Mn |
| May 31, 2015 | 1.99 Mn |
| May 31, 2015 | 1.99 Mn |
| Feb 28, 2015 | 1.68 Mn |
| Feb 28, 2015 | 1.68 Mn |
| Nov 30, 2014 | 1.71 Mn |
| Nov 30, 2014 | 1.71 Mn |